ROYCE & ASSOCIATES LP - CANCER GENETICS INC ownership

Quarter-by-quarter ownership
ROYCE & ASSOCIATES LP ownership history of CANCER GENETICS INC
ValueSharesWeighting
Q3 2015$136,000
-79.7%
17,400
-69.4%
0.00%
-66.7%
Q2 2015$669,000
+50.7%
56,9000.0%0.00%
+50.0%
Q1 2015$444,000
+16.8%
56,9000.0%0.00%
+100.0%
Q4 2014$380,00056,9000.00%
Other shareholders
CANCER GENETICS INC shareholders Q3 2023
NameSharesValueWeighting ↓
Stonepine Capital Management, LLC 1,391,607$1,239,0000.75%
PERKINS CAPITAL MANAGEMENT INC 1,004,550$894,0000.64%
Fairbanks Capital Management, Inc. 234,170$208,0000.24%
DIKER MANAGEMENT LLC 64,365$57,0000.02%
Granahan Investment Management 276,417$246,0000.02%
WEDBUSH SECURITIES INC 52,310$47,0000.01%
Court Place Advisors, LLC 10,000$9,0000.00%
SeaCrest Wealth Management, LLC 11,000$10,0000.00%
Renaissance Technologies 1,068,700$1,317,0000.00%
PANAGORA ASSET MANAGEMENT INC 43,664$39,0000.00%
View complete list of CANCER GENETICS INC shareholders